
RIGL Market Cap & Key Metrics
Rigel Pharmaceuticals, Inc.
$41.19
-$1.34(-3.15%)
56
Overall
80
Value
27
Tech
63
Quality
Market Cap
$775.61M
Volume
290.57K
52W Range
$24.95 - $52.61
Target Price
$64.40
RIGL market cap is $775.61M. This page lists Rigel Pharmaceuticals, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
RIGL Key Metrics
- Market cap
- $775.61M
- P/E ratio (current-year EPS estimate)
- 13.87
- EPS estimate, current year
- $2.97
- EPS growth, 3-year
- +0.00%
- Value score
- 80
- Quality score
- 63
- Technical score
- 27
| Fiscal year | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|
| Revenue | $28.89M | $8.25M | $7.15M | $2.25M | $4.75M |
| EBITDA | -$50.02M | -$88.55M | -$86.44M | -$96.41M | -$83.99M |
| EPS | - | - | - | $-1.32 | $-13.60 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RIGL | $41.19 | -3.2% | 290.57K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Rigel Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW